Korro Bio, Inc.
KRRO
$10.18
-$0.90-8.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | 18.53% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | 18.53% | |||
| Cost of Revenue | 28.11% | -23.66% | |||
| Gross Profit | -50.76% | 28.18% | |||
| SG&A Expenses | 9.84% | -5.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 18.99% | -15.51% | |||
| Operating Income | -28.67% | 17.44% | |||
| Income Before Tax | 60.47% | -173.55% | |||
| Income Tax Expenses | -85.06% | -- | |||
| Earnings from Continuing Operations | 60.78% | -177.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 60.78% | -177.07% | |||
| EBIT | -28.67% | 17.44% | |||
| EBITDA | -31.65% | 15.64% | |||
| EPS Basic | 68.17% | -176.38% | |||
| Normalized Basic EPS | -6.45% | 17.75% | |||
| EPS Diluted | 68.17% | -176.38% | |||
| Normalized Diluted EPS | -6.45% | 17.75% | |||
| Average Basic Shares Outstanding | 23.19% | 0.25% | |||
| Average Diluted Shares Outstanding | 23.19% | 0.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||